Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 6
1996 5
1997 3
1998 1
1999 3
2000 3
2001 1
2003 3
2004 1
2005 1
2006 7
2007 7
2008 3
2009 1
2010 3
2011 1
2012 4
2013 5
2014 5
2015 3
2016 2
2017 7
2018 5
2019 11
2020 8
2021 1
2022 2
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comments.
Tarcan T. Tarcan T. J Urol. 2023 Apr;209(4):782-783. doi: 10.1097/JU.0000000000003157.01. Epub 2023 Jan 19. J Urol. 2023. PMID: 36655475 No abstract available.
Flavoxate: present and future.
Arcaniolo D, Conquy S, Tarcan T. Arcaniolo D, et al. Among authors: tarcan t. Eur Rev Med Pharmacol Sci. 2015;19(5):719-31. Eur Rev Med Pharmacol Sci. 2015. PMID: 25807422 Free article. Review.
Management of Female and Functional Urology Patients During the COVID Pandemic.
López-Fando L, Bueno P, Carracedo D, Averbeck M, Castro-Díaz DM, Chartier-Kastler E, Cruz F, Dmochowski R, Finazzi-Agrò E, Hajebrahimi S, Heesakkers J, Kasyan G, Tarcan T, Peyronnet B, Plata M, Padilla-Fernández B, Van Der Aa F, Arlandis S, Hashim H. López-Fando L, et al. Among authors: tarcan t. Eur Urol Focus. 2020 Sep 15;6(5):1049-1057. doi: 10.1016/j.euf.2020.05.023. Epub 2020 Jun 12. Eur Urol Focus. 2020. PMID: 32540267 Free PMC article. Review.
Safety and efficacy of an α1 -blocker plus mirabegron compared with an α1 -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.
Herschorn S, Tarcan T, Jiang YH, Chung E, Abdul Hadi F, Steup A, Sumarsono B. Herschorn S, et al. Among authors: tarcan t. Neurourol Urodyn. 2024 Mar;43(3):604-619. doi: 10.1002/nau.25399. Epub 2024 Jan 30. Neurourol Urodyn. 2024. PMID: 38291827 Review.
103 results